Log In
Print
BCIQ
Print
Print this Print this
 

Enbrel, etanercept

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionRecombinant p75 tumor necrosis factor (TNF) receptor linked to the Fc portion of human IgG1 (TNFr:Fc)
Molecular Target Tumor necrosis factor (TNF) alpha ; Lymphotoxin alpha
Mechanism of ActionTumor necrosis factor (TNF) alpha inhibitor
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$68,000.0M

$22,500.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today